Editorial: SARS-CoV-2: implications for maternal-fetal-infant and perinatal mortality, morbidity, pregnancy outcomes and well-being
- PMID: 38390282
- PMCID: PMC10882071
- DOI: 10.3389/fped.2024.1375501
Editorial: SARS-CoV-2: implications for maternal-fetal-infant and perinatal mortality, morbidity, pregnancy outcomes and well-being
Keywords: COVID-19 vaccination; SARS-CoV-2; post-acute COVID-19 syndrome; pregnancy outcomes infectious/epidemiology: infant outcomes infectious/epidemiology; premature birth/epidemiology.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Figures
References
-
- Organization WH. WHO COVID-19 dashboard. (2024).
-
- Zambrano LD, Ellington S, Strid P, Galang RR, Oduyebo T, Tong VT, et al. Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status—United States, January 22–October 3, 2020. MMWR Morb Mortal Wkly Rep. (2020) 69(44):1641–7. 10.15585/mmwr.mm6944e3 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
